Dr. Eric Shifrut
Medicine, Life Sciences
Cancer Immunotherapy has dramatically revitalized immuno-oncology, but many challenges still remain. We develop and leverage CRISPR-based platforms in primary human T cells to discover ways to engineer robust anti-tumor immunity. Our goal is to design breakthrough cell-based therapies and learn how to engineer immune cells to function in the suppressive tumor microenvironment.
Medicine
- School of Medicine
Life Sciences
- School of Neurobiology, Biochemistry & Biophysics
The postdoctoral fellow will work directly with the PI to develop their project, focused on the lab themes of immuno-oncology and cell engineering. The fellow is also expected to support and mentor our junior student scientists. The fellow will participate and contribute to our group meetings, departmental seminars and relevant research symposiums. The fellowship is fully supported by grant funding, and the fellow is encouraged to apply to additional competitive funding.
Application Deadline: Jul 31, 2023
The ideal candidate would have a Ph.D. or MD/Ph.D. in immunology, genetics, molecular biology or related fields. Experimental skills in cellular immunology, such as culture of primary cells, flow cytometry (incl. intracellular cytokine staining) are required. We value strong work ethics, resilience and independence across our team. Advantage will be given to candidates with experience in genomics methods (e.g. RNA-Seq, NGS). Strong analytical, communication and problem-solving skills are desired.
